Intech Investment Management LLC Has $662,000 Stake in Trupanion, Inc. $TRUP

Posted by George Bondi on Jun 9th, 2026

Intech Investment Management LLC decreased its holdings in Trupanion, Inc. (NASDAQ:TRUP – Free Report) by 60.8% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 17,726 shares of the financial services provider’s stock after selling 27,512 shares during the quarter. Intech Investment Management LLC’s holdings in Trupanion were worth $662,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Federated Hermes Inc. acquired a new stake in Trupanion in the 3rd quarter worth about $33,000. Kelleher Financial Advisors acquired a new stake in Trupanion in the 3rd quarter worth about $74,000. PNC Financial Services Group Inc. raised its stake in Trupanion by 21.7% in the 3rd quarter. PNC Financial Services Group Inc. now owns 2,678 shares of the financial services provider’s stock worth $116,000 after purchasing an additional 478 shares in the last quarter. AlphaQuest LLC raised its stake in Trupanion by 16.5% in the 3rd quarter. AlphaQuest LLC now owns 3,444 shares of the financial services provider’s stock worth $149,000 after purchasing an additional 487 shares in the last quarter. Finally, Advisory Services Network LLC acquired a new stake in Trupanion in the 3rd quarter worth about $160,000.

Insider Buying and Selling

In other Trupanion news, COO John R. Gallagher sold 3,603 shares of the business’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $21.69, for a total transaction of $78,149.07. Following the sale, the chief operating officer directly owned 33,065 shares of the company’s stock, valued at $717,179.85. The trade was a 9.83% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Fawwad Qureshi sold 6,177 shares of the business’s stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $22.18, for a total transaction of $137,005.86. Following the sale, the chief financial officer directly owned 2,081 shares in the company, valued at $46,156.58. The trade was a 74.80% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 11,132 shares of company stock worth $248,680 over the last three months. Insiders own 5.58% of the company’s stock.

Trupanion Trading Up 0.2%

TRUP opened at $22.05 on Tuesday. Trupanion, Inc. has a fifty-two week low of $21.16 and a fifty-two week high of $57.88. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.73 and a quick ratio of 1.73. The firm has a market capitalization of $961.82 million, a price-to-earnings ratio of 37.37 and a beta of 1.45. The company’s 50 day moving average price is $24.45 and its two-hundred day moving average price is $29.60.

Trupanion (NASDAQ:TRUP – Get Free Report) last posted its earnings results on Thursday, April 30th. The financial services provider reported $0.11 earnings per share for the quarter, topping analysts’ consensus estimates of $0.07 by $0.04. Trupanion had a net margin of 1.74% and a return on equity of 6.87%. The firm had revenue of $384.05 million for the quarter, compared to analyst estimates of $379.77 million. During the same period in the previous year, the firm posted ($0.03) EPS. The company’s revenue for the quarter was up 12.3% compared to the same quarter last year. As a group, research analysts predict that Trupanion, Inc. will post 0.53 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on TRUP shares. Zacks Research cut shares of Trupanion from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 13th. Bank of America decreased their target price on shares of Trupanion from $63.00 to $59.00 and set a “buy” rating on the stock in a report on Tuesday, April 14th. Cantor Fitzgerald decreased their target price on shares of Trupanion from $42.00 to $34.00 and set a “neutral” rating on the stock in a report on Thursday, April 9th. Weiss Ratings reissued a “sell (d+)” rating on shares of Trupanion in a report on Monday, June 1st. Finally, Stifel Nicolaus decreased their target price on shares of Trupanion from $35.00 to $31.00 and set a “hold” rating on the stock in a report on Tuesday, March 31st. Two analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $42.25.

View Our Latest Stock Report on Trupanion

About Trupanion

(Free Report)

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.